CTE - Cardiotech Intl. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CTE - Cardiotech Intl.

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: bvortex who wrote (1)	6/5/2000 1:04:00 AM
From: bvortex	Read Replies (1) of 6

CTE just received European approval to run a series of clinical trials on their new Peripheral Grafts for use in lower leg traumas. This has been a long overlooked area and their new product is the only solution on the horizon. This new graft will be of most interest to diabetics and any patient needing better circulation below the knee and into the smaller capillaries in the feet/toes. The estimated market for this type of graft is #350MM alone. The stock has had a great snapback from 1.10 back to 1.88-1.94. Hold on for a fast ride. Bvortex

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next